Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study

BACKGROUND: Non-selective beta-blockers (NSBBs), e.g. propranolol, are recommended for prophylaxis of variceal bleeding in cirrhosis. Carvedilol, a newer NSBB with additional anti-α1-adrenergic activity, is superior to propranolol in reducing portal pressure. Repeated HVPG measurements are required...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Exp Hepatol
Hlavní autoři: Kirnake, Vijendra, Arora, Anil, Gupta, Varun, Sharma, Praveen, Singla, Vikas, Bansal, Naresh, Goyal, Mohan, Chawlani, Romesh, Kumar, Ashish
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5052372/
https://ncbi.nlm.nih.gov/pubmed/27746613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2016.01.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky